5 Key Takeaways

• 1

  A study of 1086 uveal melanoma patients suggests that hepatic surveillance may be effective for only five years post-treatment.

• 2

  29% of patients developed liver metastases, with 93% detected within the first five years of surveillance.

• 3

  Surveillance protocols currently impose significant imaging burdens, particularly with the use of MRI in resource-constrained systems.

• 4

  Increasing T stage and tumor location significantly influence metastatic risk, indicating a need for tailored follow-up.

• 5

  The study advocates for rethinking surveillance protocols to focus on personalized strategies rather than a one-size-fits-all approach.